Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors

NCT01980667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: lurbinectedin (PM01183)
DRUG: Cisplatin

Sponsor

PharmaMar